Suchen Sie nach Informationen zu Eisai-Hauptquartier Japan? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://www.eisai.com/index.html
Sustainability. 29 countries 2.05 billion tablets. Number of countries supplied with lymphatic filariasis treatment. and volume supplied (as of April 2022) Eisai is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries. Sustainability Management.
https://us.eisai.com/who-we-are/our-locations
Our Discovery Centers are embodiments of our huge investments in oncology and neurology innovation. At the Eisai Center for Genetics Guided Dementia Discovery (G2D2) in Cambridge, MA, some of the best minds in human genetics, data sciences and precision chemistry collaborate to accelerate discovery of breakthrough immunodementia precision ...
https://www.northernsteelvic.com.au/e-corporate-office/eisai-headquarters-japan.html
Eisai Co., Ltd. Date Established: December 6, 1941 History; Head Office: 4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan Google Maps; Japan Business Sites; Telephone: 81-3-3817-3700: Representatives: Haruo Naito, Representative Corporate Officer and CEO Yasushi Okada, Representative Corporate Officer and COO
https://en.wikipedia.org/wiki/Eisai_%28company%29
https://www.dnb.com/business-directory/company-profiles.eisai_co_ltd.15fed8175b1604f4746d29baf5c38a73.html
Find company research, competitor information, contact details & financial data for EISAI CO., LTD. of BUNKYO-KU, TOKYO. Get the latest business insights from Dun & Bradstreet. ... TOKYO, 112-0002 Japan See other locations Phone: ...
https://craft.co/eisai/locations
Eisai headquarters and office locations. Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit. Button CTA. Locations. Country City Address; Japan: Bunkyo City: 4 Chome-6-10 Koishikawa. HQ. United States: Baltimore: 6611 Tributary St #1: United States: Cambridge: 35 Cambridgepark Dr: United States: Exton: 210 Welsh Pool Rd ...
http://www.eisai.ch/about-eisai/eisai-global/
Eisai employs over 11,000 people worldwide, with operations in the U.S., Asia, Europe, the Middle East and its domestic home market of Japan. Eisai's key areas of commercial focus are neurology and oncology, with an R&D focus in three key areas: Neuroscience including: Epilepsy, Alzheimer's disease, pain and weight loss. Oncology including ...
We focus on areas of great medical need that others avoid. Learn about cutting-edge therapies that we've created for patients and their families worldwide. We’re addressing both the causes and symptoms of extremely challenging diseases. Our goal: helping patients whose needs might otherwise be ignored.
https://en.wikipedia.org/wiki/Eisai
Myōan Eisai/Yōsai (明菴栄西, 27 May 1141 – 1 August 1215) was a Japanese Buddhist priest, credited with founding the Japanese line of the Rinzai school of Zen Buddhism. In 1191, he introduced this Zen approach to Japan, following his trip to China from 1187 to 1191, during which he was initiated into the Linji school by the master Hsü an. It is also said that he …
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Eisai-Hauptquartier Japan gefunden haben.
